Back to search

Article

Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma

2022-04-12

Abstract excerpt

<h4>Background: </h4> LINC00173 had been reported as a cisplatin (cis-diamminedichloroplatinum, DDP) chemotherapy-resistant inducer in small cell lung cancer (SCLC) and lung squamous cell carcinoma (LUSC). Here, reversed data was displayed for LINC00173 as a DDP chemosensitivity-inducing factor in lung adenocarcinoma (LUAD). Methods LINC00173 was screened from GEO databases (GSE43493), then In situ hybridization...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4bd9b3c2-fa3e-5a1b-83b5-0128b0eb6d03
DOI
10.21203/rs.3.rs-1518812/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinomaDOI 10.21203/rs.3.rs-1518812/v1
Select a neighboring publication to make it the new centre.